What bothered me most was the increase in staff costs from $500,000 the previous quarter to now $700,000. I have emailed the investor relations person with a few questions - that is, is it extra sales staff. If anything useful comes back, I will post.
Before Osteopore products can be sold on the Chinese mainland, they have to pass trials, so probably a couple of years.
What bothered me most was the increase in staff costs from...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.853M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 4.1¢ | $14.65K | 351.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1950763 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 266362 | 1 |
View Market Depth
| Last trade - 11.00am 02/09/2024 (20 minute delay) ? |
| OSX (ASX) Chart |